AdAlta Limited

—As of Sun 8 Nov 2026, 12:00 UTC
ASX:1ADHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (32.31%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.16
PE TTM —
TSR TTM (14.29%)
Mkt cap A$9.637M
ROIC (344.65%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0034
12.90%
132.00%
Hold 12|1|1|10|7
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
25.60%
17.02%
8.92%
5.97%
Revenue$M
0.480
0.506
0.518
0.514
6.34%
11.39%
10.16%
8.46%
Peers (US$6.618M)
Cap (US$)
PE
8.031M
—
7.761M
—
6.612M
—
Capital
TTM
5Y
10Y
Leveragex
1.393
1.082
1.098
EBIT/Intx
6.191
3.871
3.658
Own earn%
61.75
(100.74)
(91.66)
Sh yield%
40.18
54.28
54.15
Owners
Insiders/Inst%
2.09
38.30
Short interest%
5.48
SBC / revenue%
1.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
3–13
$1 testx
—
Incr. ROIC%
8